After tough period for lobby, BIO chief Michelle McMurry-Heath goes on leave
WASHINGTON — Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington, is on leave from her role as CEO of the Biotechnology Innovation Organization, the group confirmed on Sunday.
“The BIO CEO is currently on leave. BIO does not speculate on rumors relative to employees or personnel,” BIO Chief Public Affairs and Marketing Officer Rich Masters said.
